Reboxetine (brand names: Edronax (AU IE IL NZ ZA UK) Prolift (AR† BR CL VE†)) is a drug of the norepinephrine reuptake inhibitor class marketed as an antidepressant by Pfizer for use in the treatment of unipolar depression. Although it has also been used off-label for panic disorder and ADHD. It is approved for use in many countries worldwide but has not been approved for use in the United States.
This page contains content from the copyrighted Wikipedia article "Reboxetine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
